Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page
- CheckyesterdayChange DetectedAdded related topics: Multiple Myeloma and MedlinePlus Genetics to the study page.SummaryDifference0.2%

- Check8 days agoChange DetectedRelated topics and the disease label 'Multiple myeloma' plus the 'MedlinePlus Genetics' link were removed; core study information remains unchanged.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded the topic Multiple myeloma and the related topic MedlinePlus Genetics. Updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check29 days agoChange DetectedRemoved the disease label 'Multiple myeloma,' the related topics header, and the 'MedlinePlus Genetics' resource.SummaryDifference0.2%

- Check37 days agoChange DetectedRevision: v3.4.3 was published, replacing the previous v3.4.2.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.